Evidence map›Paper›PMID 42654436›Full record

ArticleMedicina (Kaunas, Lithuania)2026

Limited Discriminatory Capacity of Continuous Glucose Monitoring in Prediabetes and Increased Diabetes Risk: A Cross-Sectional Study.

Dóra Marietta Balogh, Karola Osgyán, Magdolna Békeffy, Miklós Kempler, Gergely Balaton, Manfredi Rizzo, Viktor József Horváth, Péter Kempler, Adrienn Menyhárt

Abstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dóra Marietta BaloghDepartment of Internal Medicine and Oncology, Semmelweis University, Korányi Sándor u. 2/a., 1083 Budapest, Hungary.
Karola OsgyánDepartment of Internal Medicine and Oncology, Semmelweis University, Korányi Sándor u. 2/a., 1083 Budapest, Hungary.
Magdolna BékeffyDepartment of Internal Medicine and Oncology, Semmelweis University, Korányi Sándor u. 2/a., 1083 Budapest, Hungary.
Miklós KemplerDepartment of Internal Medicine and Haematology, Semmelweis University, Szentkirályi u. 46., 1088 Budapest, Hungary.
Gergely BalatonDepartment of Paediatric Dentistry and Orthodontics, Semmelweis University, Szentkirályi u. 47., 1088 Budapest, Hungary.
Manfredi RizzoSchool of Medicine, ProMISE Department, University of Palermo, 90133 Palermo, Italy.ORCID 0000-0002-9549-8504
Viktor József HorváthDepartment of Internal Medicine and Oncology, Semmelweis University, Korányi Sándor u. 2/a., 1083 Budapest, Hungary.ORCID 0000-0002-7888-2651
Péter KemplerDepartment of Internal Medicine and Oncology, Semmelweis University, Korányi Sándor u. 2/a., 1083 Budapest, Hungary.ORCID 0000-0002-6072-8832
Adrienn MenyhártDepartment of Internal Medicine and Oncology, Semmelweis University, Korányi Sándor u. 2/a., 1083 Budapest, Hungary.ORCID 0009-0008-8613-2341

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Blood GlucoseContinuous Glucose MonitoringPrediabetic StateAdultAgedCross-Sectional StudiesFemaleGlycated HemoglobinHumansMaleMiddle AgedRisk FactorsBlood GlucoseGlycated Hemoglobincontinuous glucose monitoringFINDRISCHbA1cprediabetes

Identifiers

PMID42654436
PMCPMC13515059

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.